Literature DB >> 20080523

Necrotizing enterocolitis in 20,822 infants: analysis of medical and surgical treatments.

Fizan Abdullah1, Yiyi Zhang, Melissa Camp, Debraj Mukherjee, Alodia Gabre-Kidan, Paul M Colombani, David C Chang.   

Abstract

Necrotizing enterocolitis (NEC) is the most common gastrointestinal emergency of the neonate. Previous information about this disease has largely been gathered from limited series. We analyzed 13 years of the National Inpatient Sample (NIS) and 3 years of the Kids' Inpatient Database (KID; 1997, 2000, 2003) to generate the most comprehensive profile of outcomes to date of medically versus surgically treated NEC. We identified 20 822 infants with NEC, of whom 15,419 (74.1%) and 5403 (25.9%) were undergoing medical and surgical management, respectively. Overall, surgical patients had greater length of stay, total hospital charges, and mortality. Among infants dying during admission, there was no significant difference in length of stay or charges between the medical and surgical groups. These findings highlight the need for developing a clinically relevant risk stratification tool to identify NEC patients at high risk for death.

Entities:  

Mesh:

Year:  2010        PMID: 20080523     DOI: 10.1177/0009922809349161

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  15 in total

Review 1.  Primary anastomosis or ostomy in necrotizing enterocolitis?

Authors:  Ramanathapura N Haricharan; Jade Palazzola Gallimore; Ahmed Nasr
Journal:  Pediatr Surg Int       Date:  2017-08-02       Impact factor: 1.827

2.  Acute kidney injury in necrotizing enterocolitis predicts mortality.

Authors:  Cory N Criss; David T Selewski; Bipin Sunkara; Joshua S Gish; Lily Hsieh; Jennifer S Mcleod; Jason O Robertson; Niki Matusko; Samir K Gadepalli
Journal:  Pediatr Nephrol       Date:  2017-10-05       Impact factor: 3.714

3.  Bacterial DNA content in the intestinal wall from infants with necrotizing enterocolitis.

Authors:  Brian T Bucher; Lucas A McDuffie; Nurmohammad Shaikh; Phillip I Tarr; Barbara B Warner; Aaron Hamvas; Frances V White; Christopher R Erwin; Brad W Warner
Journal:  J Pediatr Surg       Date:  2011-06       Impact factor: 2.545

4.  Necrotizing Enterocolitis in Infants with Hypoplastic Left Heart Syndrome Following Stage 1 Palliation or Heart Transplant.

Authors:  Nahed O ElHassan; Xinyu Tang; Jeffrey Gossett; Dala Zakaria; Ashley Ross; Sashi K Kona; Parthak Prodhan
Journal:  Pediatr Cardiol       Date:  2018-02-01       Impact factor: 1.655

5.  Neonatal independent predictors of severe NEC.

Authors:  Miriam Duci; Francesco Fascetti-Leon; Marta Erculiani; Elena Priante; Maria Elena Cavicchiolo; Giovanna Verlato; Piergiorgio Gamba
Journal:  Pediatr Surg Int       Date:  2018-04-11       Impact factor: 1.827

Review 6.  A clinical perspective of necrotizing enterocolitis: past, present, and future.

Authors:  Renu Sharma; Mark Lawrence Hudak
Journal:  Clin Perinatol       Date:  2013-01-17       Impact factor: 3.430

7.  Discrimination of GutCheck(NEC): a clinical risk index for necrotizing enterocolitis.

Authors:  S M Gephart; A R Spitzer; J A Effken; E Dodd; M Halpern; J M McGrath
Journal:  J Perinatol       Date:  2014-03-20       Impact factor: 2.521

8.  Necrotizing Enterocolitis among Very-Low-Birth-Weight Infants in Korea.

Authors:  Young Ah Youn; Ee-Kyung Kim; So Young Kim
Journal:  J Korean Med Sci       Date:  2015-10-27       Impact factor: 2.153

9.  Abnormal heart rate characteristics before clinical diagnosis of necrotizing enterocolitis.

Authors:  M L Stone; P M Tatum; J-H Weitkamp; A B Mukherjee; J Attridge; E D McGahren; B M Rodgers; D E Lake; J R Moorman; K D Fairchild
Journal:  J Perinatol       Date:  2013-05-30       Impact factor: 2.521

10.  Reducing necrotizing enterocolitis in very low birth weight infants using quality-improvement methods.

Authors:  A L Patel; S Trivedi; N P Bhandari; A Ruf; C M Scala; G Witowitch; Y Chen; C Renschen; P P Meier; J M Silvestri
Journal:  J Perinatol       Date:  2014-07-10       Impact factor: 2.521

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.